Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Common Stock, $0.00001 par value per share
-
Shares outstanding
-
20,250,000
-
Total 13F shares
-
4,248,631
-
Share change
-
+2,004,824
-
Total reported value
-
$21,838,067
-
Put/Call ratio
-
5.5%
-
Price per share
-
$5.14
-
Number of holders
-
29
-
Value change
-
+$10,299,470
-
Number of buys
-
19
-
Number of sells
-
7
Institutional Holders of enVVeno Medical Corp - Common Stock, $0.00001 par value per share (NVNO) as of Q4 2023
As of 31 Dec 2023,
enVVeno Medical Corp - Common Stock, $0.00001 par value per share (NVNO) was held by
29 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
4,248,631 shares.
The largest 10 holders included
Nantahala Capital Management, LLC, PERCEPTIVE ADVISORS LLC, KINGDON CAPITAL MANAGEMENT, L.L.C., ARMISTICE CAPITAL, LLC, Altium Capital Management LP, VANGUARD GROUP INC, Rosalind Advisors, Inc., UBS OCONNOR LLC, Velan Capital Investment Management LP, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
29
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.